Related Experiment Video
Updated: Aug 18, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Pediatric asthma: "Real world" measures of effectiveness
1Department of Allergy, Immunology, and Pulmonary Medicine, Children's National Medical Center, George Washington University School of Health Science, Washington, DC, USA. rfink@cnmc.org
Insights
Assessing pediatric asthma interventions requires careful consideration of cost-effectiveness and therapeutic value. Long-term trials measuring real-world outcomes, including patient quality of life and adherence, are crucial for accurate evaluation.
Area of Science:
- Pediatric Pulmonology
- Health Economics
- Clinical Trial Design
Background:
- Evaluating pediatric asthma interventions presents challenges in measuring cost-effectiveness and therapeutic value.
- Variability in asthma symptoms, patient selection biases, and outcome assessment in children complicate trial validity.
- Real-world conditions, broad-based outcomes, and long-term quality of life are essential for effective asthma intervention assessment.
Purpose of the Study:
- To provide guidance on properly assessing the cost and therapeutic value of pediatric asthma interventions.
- To highlight key parameters for determining cost-effectiveness in pediatric asthma treatment.
- To emphasize the importance of real-world data and long-term evaluation in clinical trials.
Main Methods:
- Discussion of challenges in pediatric asthma clinical trials, including patient selection and outcome measurement.
- Emphasis on incorporating objective pulmonary function and subjective quality-of-life measures.
- Consideration of patient adherence as a critical variable influenced by drug characteristics and quality of life.
Main Results:
- Cost-effectiveness and therapeutic value assessment in pediatric asthma are complex.
- Subtle biases and variable symptomatology can impact measurement validity.
- Long-term, real-world data including patient adherence and quality of life are vital.
Conclusions:
- Accurate assessment of pediatric asthma interventions necessitates long-term, real-world data.
- Patient adherence and quality of life significantly influence treatment effectiveness.
- Comprehensive evaluation requires broad-based outcome measures in clinical trials.
Abstract:
In the treatment of pediatric asthma, measuring the effectiveness of an intervention in terms of cost or therapeutic value can be a challenging process. Parameters that should be considered in determining the cost effectiveness of an intervention vary considerably. In clinical therapeutic trials of pediatric asthma, subtle patient selection biases, difficulties in choosing and assessing treatment outcomes in young children, and the highly variable nature of asthma symptomatology can compromise valid measurements of the therapeutic effectiveness of an intervention. Ideally, outcome measurements in asthma should reflect "real world" conditions. They should be as broad-based as possible and include both objective measures of pulmonary function and subjective measures of quality-of-life evaluated over the long term. Patient adherence is thus a critical variable that influences the ultimate effectiveness of treatment. The rate of patient adherence is influenced not only by drug characteristics such as route of administration and dosing frequency, but also by the impact of treatment on a patient's quality of life. Because asthma is a chronic disease with variable symptomatology, clinical trials investigating the cost and therapeutic effectiveness of asthma interventions must evaluate real-world variables in long-term trials. This article will provide information regarding proper assessment of an intervention's cost and therapeutic value.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
First, in...
01:23Inhaled Medications